Pfizer Inc.
Pfizer Inc.（PFE）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · PFE · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
0
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Pfizer Inc.内部人在过去近12个月买卖活动混合。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
PFE 季度内部人买卖趋势
PFE 内幕交易卖出 · PFE 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · PFE CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
PFE 高管卖出股份 · PFE 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Mar 3, 2026 | DAMICO JENNIFER B. SVP & Controller | Award | 5,408 | — | Form 4 |
| Mar 4, 2026 | DAMICO JENNIFER B. SVP & Controller | Other | 826 | $22K | Form 4 |
| Mar 3, 2026 | DAMICO JENNIFER B. SVP & Controller | Award | 16,311 | — | Form 4 |
| Feb 27, 2026 | DAMICO JENNIFER B. SVP & Controller | Other | 655 | $18K | Form 4 |
| Feb 25, 2026 | SAHNI PAYAL EVP | Option | 56,888 | $1.92M⚡ | Form 4 |
| Feb 25, 2026 | SAHNI PAYAL EVP | Other | 1,083 | $29K | Form 4 |
| Feb 25, 2026 | SAHNI PAYAL EVP | Other | 54,066 | $1.46M⚡ | Form 4 |
| Feb 25, 2026 | LANKLER DOUGLAS M EVP | Option | 122,907 | $4.16M⚡ | Form 4 |
| Feb 25, 2026 | LANKLER DOUGLAS M EVP | Other | 2,198 | $60K | Form 4 |
| Feb 25, 2026 | LANKLER DOUGLAS M EVP | Other | 116,811 | $3.14M⚡ | Form 4 |
| Feb 25, 2026 | DAMICO JENNIFER B. SVP & Controller | Option | 17,558 | $594K | Form 4 |
| Feb 25, 2026 | DAMICO JENNIFER B. SVP & Controller | Other | 361 | $10K | Form 4 |
| Feb 25, 2026 | DAMICO JENNIFER B. SVP & Controller | Other | 16,687 | $449K | Form 4 |
| Feb 25, 2026 | BOURLA ALBERT Chairman & CEO · Director | Option | 491,626 | $16.63M⚡ | Form 4 |
| Feb 25, 2026 | BOURLA ALBERT Chairman & CEO · Director | Other | 8,303 | $225K | Form 4 |
| Feb 25, 2026 | BOURLA ALBERT Chairman & CEO · Director | Other | 467,241 | $12.58M⚡ | Form 4 |
| Feb 25, 2026 | Fonseca Lidia EVP | Option | 56,888 | $1.92M⚡ | Form 4 |
| Feb 25, 2026 | Fonseca Lidia EVP | Other | 1,058 | $29K | Form 4 |
| Feb 25, 2026 | Fonseca Lidia EVP | Other | 54,066 | $1.46M⚡ | Form 4 |
| Feb 25, 2026 | McDermott Michael EVP | Option | 37,925 | $1.28M⚡ | Form 4 |
| Feb 25, 2026 | McDermott Michael EVP | Other | 679 | $18K | Form 4 |
| Feb 25, 2026 | McDermott Michael EVP | Other | 36,044 | $970K | Form 4 |
| Feb 26, 2026 | McDermott Michael EVP | Other | 3,503 | $95K | Form 4 |
| Feb 25, 2026 | BOSHOFF CHRISTOFFEL President, R&D | Award | 13,383 | — | Form 4 |
| Feb 25, 2026 | BOSHOFF CHRISTOFFEL President, R&D | Other | 6,833 | $185K | Form 4 |
BOURLA ALBERT
Chairman & CEO · Director
日期
Feb 25
股数
491,626
均价
$33.82
总金额
$16.63M ⚡
BOURLA ALBERT
Chairman & CEO · Director
日期
Feb 25
股数
467,241
均价
$26.92
总金额
$12.58M ⚡
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 PFE 内幕交易
PFE 内幕交易
Pfizer Inc.（PFE）内幕交易数据来源于公司内部人（包括DAMICO JENNIFER B. (SVP & Controller), McDermott Michael (EVP), BOSHOFF CHRISTOFFEL (President, R&D)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。PFE内部人近期买卖活动混合，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Pfizer Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
PFE 内幕交易 · 5个问题Pfizer Inc.（PFE）的内部人包括高管和董事，如DAMICO JENNIFER B. (SVP & Controller), McDermott Michael (EVP), BOSHOFF CHRISTOFFEL (President, R&D)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026